HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM
Clinical trials for HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine aims to better protect transplant patients against COVID-19
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new type of COVID-19 vaccine (LUNAR-COV19) in adults who have had a stem cell transplant. These patients often have weaker immune responses to standard vaccines. The new vaccine uses a self-amplifying mRNA that may create a stronger and longer-lasting immune de…
Matched conditions: HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 19, 2026 11:46 UTC
-
New drug aims to stop transplant complications in blood cancer patients
Disease control Not yet recruitingThis study tests whether adding the drug axatilimab to standard care can prevent graft-versus-host disease (GVHD) in blood cancer patients receiving a stem cell transplant from a donor. GVHD occurs when donor cells attack the patient's body, causing symptoms like skin rash, dry e…
Matched conditions: HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
Magic mushroom compound may ease cancer pain without heavy drugs
Symptom relief Not yet recruitingThis study tests whether a low dose of psilocybin (a compound from magic mushrooms) combined with talk therapy is safe and helpful for easing chronic cancer pain in 20 adults who already take opioids. Participants will receive psilocybin in a supervised setting and undergo counse…
Matched conditions: HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC
-
Can archetype therapy ease Cancer's existential pain?
Symptom relief Not yet recruitingThis study tests a 6-session spiritual health program called PATH for cancer patients struggling with feelings of disconnection, loss of meaning, or spiritual distress. About 20 adults with any cancer type will try the program, which uses role-playing and therapy techniques to he…
Matched conditions: HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated May 08, 2026 12:04 UTC
-
New study aims to unravel immune secrets of chronic GVHD
Knowledge-focused Not yet recruitingThis study looks at why some people develop chronic graft-versus-host disease (GVHD) after a stem cell transplant. Researchers will analyze immune cells in blood and affected tissues from 75 participants. The goal is to better understand the disease, not to test a new treatment.
Matched conditions: HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:13 UTC